Dihydropyridine Calcium Channel Blocker [EPC]

231428 reported adverse events

Drugs of this class: NIFEDIPINE FELODIPINE NIMODIPINE ISRADIPINE NISOLDIPINE FELODIPINE EXTENDED-RELEASE TABLETS AMLODIPINE AMLODIPINE AND OLMESARTAN MEDOXOMIL CLEVIDIPINE CLEVIPIDINE OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET 40/10/25 MG

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

# Side effect Count
0 FATIGUE 12693
1 DYSPNOEA 12541
2 DIARRHOEA 11731
3 NAUSEA 11649
4 DRUG INEFFECTIVE 10628
5 DIZZINESS 9792
6 HEADACHE 8873
7 ACUTE KIDNEY INJURY 7980
8 PAIN 7935
9 ASTHENIA 7760
See all common reactions for Dihydropyridine Calcium Channel Blocker [EPC]

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-CARDIOGENIC PULMONARY OEDEMA 232 0.3542
1 GINGIVAL HYPERTROPHY 293 0.3174
2 HYPERPARATHYROIDISM SECONDARY 626 0.2857
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 257 0.2824
4 DISTRIBUTIVE SHOCK 200 0.2743
5 NEPHROGENIC ANAEMIA 1119 0.2693
6 GINGIVAL HYPERPLASIA 150 0.2488
7 VASOPLEGIA SYNDROME 202 0.2371
8 BLOOD PRESSURE SYSTOLIC ABNORMAL 248 0.1975
9 BLOOD PRESSURE DIASTOLIC ABNORMAL 266 0.1833
See all enriched reactions for Dihydropyridine Calcium Channel Blocker [EPC]